Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Acute Coronary Syndrome Patients With a High Risk of Ischemic Events

Circ Cardiovasc Interv. 2021 Aug;14(8):e010812. doi: 10.1161/CIRCINTERVENTIONS.121.010812. Epub 2021 Jul 20.

Abstract

[Figure: see text].

Trial registration: ClinicalTrials.gov NCT02494895.

Keywords: acute coronary syndrome; ischemia; myocardial infarction; stroke; ticagrelor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Aspirin / adverse effects
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Ticagrelor / adverse effects

Substances

  • Platelet Aggregation Inhibitors
  • Ticagrelor
  • Aspirin

Associated data

  • ClinicalTrials.gov/NCT02494895